PALMI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 5.428
AS - Asia 2.440
EU - Europa 2.353
SA - Sud America 300
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 52
OC - Oceania 5
Totale 10.743
Nazione #
US - Stati Uniti d'America 5.130
SG - Singapore 1.029
IT - Italia 705
CN - Cina 476
DE - Germania 330
HK - Hong Kong 328
RU - Federazione Russa 318
BR - Brasile 229
CA - Canada 221
VN - Vietnam 210
SE - Svezia 206
IE - Irlanda 174
UA - Ucraina 122
GB - Regno Unito 111
FR - Francia 107
FI - Finlandia 66
IN - India 65
BD - Bangladesh 46
TR - Turchia 44
AT - Austria 36
NL - Olanda 36
IQ - Iraq 33
ID - Indonesia 29
KR - Corea 27
MX - Messico 27
AR - Argentina 26
ES - Italia 25
PK - Pakistan 24
PL - Polonia 24
BE - Belgio 22
JP - Giappone 22
SA - Arabia Saudita 17
ZA - Sudafrica 15
DK - Danimarca 13
UZ - Uzbekistan 13
VE - Venezuela 13
CH - Svizzera 11
CO - Colombia 11
PH - Filippine 11
JO - Giordania 9
JM - Giamaica 8
MA - Marocco 8
CL - Cile 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
EC - Ecuador 6
IL - Israele 6
KE - Kenya 6
LB - Libano 6
LT - Lituania 6
PR - Porto Rico 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
NI - Nicaragua 5
OM - Oman 5
TH - Thailandia 5
TW - Taiwan 5
GR - Grecia 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CZ - Repubblica Ceca 3
EU - Europa 3
GP - Guadalupe 3
HN - Honduras 3
HU - Ungheria 3
KZ - Kazakistan 3
PA - Panama 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AO - Angola 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
SR - Suriname 2
TN - Tunisia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BT - Bhutan 1
CM - Camerun 1
CY - Cipro 1
GE - Georgia 1
GL - Groenlandia 1
GT - Guatemala 1
Totale 10.568
Città #
Singapore 681
Ashburn 602
Ann Arbor 541
Fairfield 320
Hong Kong 320
San Jose 289
Woodbridge 270
Houston 251
Chandler 249
Frankfurt am Main 211
Dublin 168
Milan 167
Seattle 138
Wilmington 132
Council Bluffs 131
New York 130
Toronto 125
Cambridge 115
Jacksonville 113
Santa Clara 102
Los Angeles 87
Dearborn 83
Beijing 76
Chicago 70
Princeton 61
Dallas 55
Ho Chi Minh City 54
Nanjing 51
Hanoi 47
Shanghai 43
Hefei 39
Boardman 36
Lissone 36
The Dalles 36
São Paulo 34
Munich 33
Vienna 33
Rome 32
Lauterbourg 31
Lawrence 29
Altamura 27
Helsinki 26
Moscow 26
Buffalo 24
Besana In Brianza 23
Columbus 23
Seoul 22
Jakarta 21
Nanchang 21
Brussels 20
Warsaw 20
Phoenix 19
Lachine 17
Denver 16
Orem 16
San Francisco 16
London 14
San Diego 14
Brooklyn 12
Jinan 12
Tashkent 12
Turku 12
Amsterdam 11
Montreal 11
Baghdad 10
Guangzhou 10
Nuremberg 10
Paris 10
Philadelphia 10
Rio de Janeiro 10
Amman 9
Bologna 9
Mountain View 9
Tianjin 9
Ankara 8
Atlanta 8
Boston 8
Brasília 8
Brugherio 8
Calgary 8
Chennai 8
Da Nang 8
Hebei 8
Kunming 8
Mexico City 8
North Bergen 8
Perugia 8
Riyadh 8
Sesto San Giovanni 8
Turin 8
Dhaka 7
Florence 7
Haiphong 7
Johannesburg 7
New Delhi 7
Norwalk 7
Padua 7
Poplar 7
Tokyo 7
Verona 7
Totale 6.750
Nome #
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 524
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 492
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 419
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 395
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia 383
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 366
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 355
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 349
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 349
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 346
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 341
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 338
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model 332
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 332
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 323
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 318
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 314
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 314
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 304
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 295
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia 294
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 293
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia 285
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? 284
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 282
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 275
A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus 258
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia 253
TEL/ARG induces cytoskeletal abnormalities in 293T cells 245
The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells 243
Treatment outcome of CRLF2 -rearranged childhood acute lymphoblastic leukaemia: A comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups 231
Gain-of-function mutations in interleukin-7 receptor-{alpha} (IL7R) in childhood acute lymphoblastic leukemias 217
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis 201
The recombinome of IKZF1 deletions in B-cell precursor ALL 193
Totale 10.743
Categoria #
all - tutte 33.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022305 0 0 0 0 43 34 16 32 14 40 38 88
2022/2023956 98 316 86 86 57 129 26 51 60 16 24 7
2023/2024677 30 16 31 47 88 191 124 35 35 15 10 55
2024/20251.363 56 136 86 52 140 40 81 40 153 227 133 219
2025/20263.509 388 141 217 432 525 190 488 156 299 288 194 191
2026/20271.081 133 127 318 457 46 0 0 0 0 0 0 0
Totale 10.743